The role of science, technology and innovation in the UN 2030 agenda

PP Walsh, E Murphy, D Horan - Technological Forecasting and Social …, 2020 - Elsevier
The transition path to inclusive and environmentally sustainable economic development
must be Science, Technology and Innovation (STI) intensive. As such, we outline an …

Addressing global health inequalities: An open licensing approach for university innovations

A Kapczynski, S Chaifetz, Z Katz, Y Benkler - Berkeley Tech. LJ, 2005 - HeinOnline
Each year, millions of people in low-and middle-income (LMI) countries die from preventable
and treatable diseases.'AIDS provides one of the starkest examples: it killed more than three …

[PDF][PDF] Intellectual property rights, anti-AIDS policy and generic drugs

F Orsi, L Hasenclever, B Fialho, P Tigre… - … of AIDS and access to HIV …, 2003 - Citeseer
The paper intends to get into Brazil's National anti-Aids Program's “black box” and unveil the
elements that drive its dynamics. The focus is on the main choices that have governed the …

Post-TRIPS technological behaviour of the pharmaceutical industry in India

D Abrol - Science, Technology and Society, 2004 - journals.sagepub.com
This paper analyses the post-TRIPs behaviour of domestic and foreign pharmaceutical firms
in respect of technology acquisition, knowledge transfer and domestic R&D in India. It …

Global Health Governance und UNAIDS–Elemente eines globalen Integrationsmodus?

L Kohlmorgen - PERIPHERIE–Politik• Ökonomie• Kultur, 2004 - budrich-journals.de
This article puts HIV/Aids in a broader context: On the background that globalisation causes
social problems and a greater interdependence in the world and infectious diseases in …

World market strategies for drugs to fight AIDS

J Dumoulin, YA Flori, P Vinard, T Borel - 2003 - ideas.repec.org
Faced with a situation where the market is unstable and the political context is crucial, we
propose a three-part analysis. In the first part, an overview of the chronology of the main …

[HTML][HTML] Brevets et accès aux médicaments dans les pays en développement

E Combe, E Pfister - Revue française d'économie, 2004 - persee.fr
Patent and Drugs in Developing Countries. This article surveys the empirical literature on
how patents affect access to drugs in developing countries. In the short run, higher prices …

[图书][B] A manufactured solution? The transfer of technology to developing countries for the local production of affordable antiretrovirals: Case Studies from Tanzania …

KR Wilson - 2009 - library-archives.canada.ca
Statement of the issue: Facing large HIV-infected populations, Sub-Saharan African
countries are producing antiretroviral (ARV) drugs under provisions of the World Trade …

A Manufactured Solution? The Transfer of Technology for the Local Production of Affordable Antiretrovirals: Case Studies from Tanzania and South Africa

KR Wilson - tspace.library.utoronto.ca
Statement of the issue: Facing large HIV-infected populations, Sub-Saharan African
countries are producing antiretroviral (ARV) drugs under provisions of the World Trade …

8.1 NEW DRUG DISCOVERY: INNOVATIVENESS, THERAPEUTIC FOCUS AND DELAY IN LAUNCH

DIN LAUNCH - Globalization and the Millennium Development …, 2007 - books.google.com
The theoretical literature on market structure and technological progress examines the
Schumpeterian proposition that monopoly is the breeding ground of innovations and R&D …